Genscript Biotech Corporation is a global biotech company. The Company’s mission is to “Make the Human and Nature Healthier through Biotechnology”. Genscript Biotech Corporation is a leading life sciences research and application service and product provider that applies its proprietary technology to various fields from basic life sciences research to translational biomedical development, industrial synthetic products, and cell therapeutic solutions.
Leveraging in the Group’s proprietary gene synthesis and other technology and know-hows, the Group has established four major platforms including (i) a leading contracted research organization (“CRO”) platform to provide one-stop solutions to global research communities; (ii) a contract development and manufacturing organization (“CDMO”) platform; (iii) an industrial synthetic products platform; and (iv) an integrated global cell therapy platform. The CRO platform remains as the strong and stable revenue generating foundation for the entire corporate. The CDMO platform provides end-to-end biologics discovery and development services to pharmaceutical, biotech, government and academic customers worldwide. The industrial synthetic products platform develops products for food and feed processing and other industrial uses. The cell therapy platform provides cell therapy solutions to patients with refractory diseases including cancer and inflammatory diseases.
Backed by gene synthesis and editing technology, the Group has made significant progress in its synthetic biology research and application, which mainly materialized into its innovative chimeric antigen receptor (“CAR”) T-cell (“CAR-T”) therapy and industrial enzyme businesses. With a strong sales and marketing team and strong research and development capabilities, the Company maintains a stable and sustainable growth.
For more information, please visit https://www.genscript.com/.
|Registered office in the
|4th Floor, Harbour Place
103 South Church Street, George Town
P.O. Box 10240, Grand Cayman KY1-1002
(information contained in these websites does not form part of
|Company secretary||Ms. Wong Wai Ling (黃慧玲)
(a member of the Hong Kong Institute of
|Authorized representatives||Dr. Zhang Fangliang (章方良)
Mr. Meng Jiange (孟建革)
|Principal share registrar
and transfer office
Harneys Services (Cayman) Limited
4th Floor, Harbour Place
103 South Church Street
P.O. Box 10240
Grand Cayman KY1-1002
|Hong Kong Share Registrar||Computershare Hong Kong Investor Services Limited
17th Floor, Hopewell Centre
183 Queen's Road East